Castrate-resistant Prostate Cancer Market Size Worth $14.5 billion by 2026 - KBV Research

The Global Castrate-resistant Prostate Cancer Market size is expected to reach $14.5 billion by 2026, rising at a market growth of 8.3% CAGR during the forecast period. Castrate-Resistant Prostate Cancer (CRPC), a variety of prostate cancer that generally recurs after managing androgen deprivation therapy (ADC), is getting prominent in the prostate cancer market.


Full Report: https://www.kbvresearch.com/castrate-resistant-prostate-cancer-market/


The Wall

No comments
You need to sign in to comment